BOB Capital Markets Ltd.
US and ROW sales grew above our estimates of 5% and 13% respectively, reporting growth of 10% each
Alembic Pharmaceuticals Ltd. is trading above all available SMAs
More from Alembic Pharmaceuticals Ltd.
Recommended